AMANDA QUARLES: Open Payments
NPI 1699084020 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 39 payments from 19 companies in 2025. Trend: 2023 $1,520 · 2024 $149 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 7 | $260 |
| ABBVIE INC. | 4 | $88 |
| EMD Serono, Inc. | 3 | $59 |
| SK Life Science, Inc. | 2 | $54 |
| Lundbeck LLC | 2 | $53 |
| Amgen Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| JAZZ PHARMACEUTICALS INC. | 2 | $41 |
| Biogen, Inc. | 2 | $41 |
| UCB, Inc. | 2 | $41 |
Products named: Ocrevus Zunovo, Ocrevus, BOTOX, VYEPTI, UPLIZNA, Symbravo, EPIDIOLEX, VUMERITY.
Industry payments across MS — which companies pay providers there.
